Skip to main content
. 2017 May 19;12(5):e0177684. doi: 10.1371/journal.pone.0177684

Table 1. Baseline characteristics (n = 390).

Age (mean±SD) 56±11
CVD risk factors (%)
    • Diabetes
    • History of dyslipidemia
    • Family history of premature CAD
    • Current smoking
    • BMI (kg/m2) (mean±SD)
    • Systolic blood pressure (mmHg)(mean±SD)
• 16
• 45
• 66
• 20
• 30±7
• 136±21
Chronic kidney disease (%) 3
History of malignancy (%) 11
Depression (%) 27
History of autoimmune disease (%) 9
Medications (%)
    • ACEI
    • ARB
    • Beta-blockers
    • Diuretics
    • Vasodilators
    • Aspirin
    • Corticosteroid
    • HMG-Co reductase inhibitors
• 21
• 3
• 33
• 25
• 7
• 51
• 4
• 20
Inflammatory biomarkers level (median)
    • IL-6
    • hs-CRP*
    • SAA
• 2.8 pg/mL (Range: 0.43–33.4 pg/mL)
• 0.37 mg/dL (Range: 0.02–16.4 mg/dL)
• 0.54 mg/dL (Range: 0.08–73 mg/dL)

*Level of <0.1 mg/dL is considered low risk for atherosclerosis.

CAD: Coronary artery disease, CVD: cardiovascular disease, BMI: body mass index, ACEI: angiotensin converting enzyme inhibitors, ARB: angiotensin receptor blockers, IL-6: interlukin-6, hs-CRP: high sensitivity C-Reactive protein, SAA: serum amyloid A.